BioCentury
ARTICLE | Company News

Boehringer Ingelheim to acquire Actimis

June 18, 2008 12:38 AM UTC

Boehringer Ingelheim (Ingelheim, Germany) said it will acquire Actimis (San Diego, Calif.) in a structured buyout tied to the development of Actimis' lead compound, AP768. The antagonist of chemoattra...